Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions
Neuropathic Pain
Interventions
DRUG

methadone tablets

The intervention with the active drug (methadone) will start with the dose of 1 tablet (5 mg) twice a day (every 12 hours) and titrated on subsequent visits up to the maximum dose of 6 tablets a day (totaling 30 mg divided into 2 daily doses to facilitate therapeutic adherence).

DRUG

Placebo

In this arm patients will take placebo tablets (the same number, color and physical aspects as the methadone tablets).

Trial Locations (1)

05403-000

University of São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT05235191 - Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies | Biotech Hunter | Biotech Hunter